Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Remdesivir drug stops novel coronavirus from replicating

Scientists from the University of Alberta have published findings that the antiviral drug remdesivir prevents replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by inhibiting RNA replication. The study, published in April 2020 in the Journal of Biological Chemistry, follows on the heels of earlier reports from the same lab in February, showing the drug's effectiveness against the related Middle East Respiratory Syndrome (MERS) virus.

15 Apr 2020

Anosmia (loss of smell) confirmed as a clinical feature of COVID-19

Earlier last month, the association of ear, nose, and throat (ENT) specialists in the UK issued a public statement advising patients with a sudden loss of smell or taste to get tested for COVID-19. They cited not only their own observations but those from numerous other ENT consultants the world around. A review of multiple papers on the sinus and nasal symptoms and signs related to the diagnosis of COVID-19, published in April 2020, in the journal Laryngoscope Investigative Otolaryngology, reiterates this finding.

15 Apr 2020

Coronavirus able to survive near boiling point of water, study shows

A startling paper by a team of French scientists published in the preprint journal bioRxiv in April 2020 suggests that the novel coronavirus is capable of surviving at high temperatures. This could mean that laboratory technicians handling the virus are at danger of infection.

15 Apr 2020

New coronavirus possibly circulated within humans before COVID-19 pandemic

Genetic variation analysis and the evidence of recombination events point towards the conclusion that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might have circulated cryptically among humans for years, as reported by a recent paper on a preprint server bioRxiv.

15 Apr 2020

ACE2 genetic variants may influence coronavirus disease progression

Researchers in British Columbia have identified a set of gene variants that are likely to influence disease progression from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to COVID-19 disease.

15 Apr 2020

Novel coronavirus can be airborne for 13 feet

The novel coronavirus can travel up to 13 feet or 4 meters from patients in hospital wards, a new study has found. This is twice the distance current guidelines recommend for social distancing.

14 Apr 2020

The race is on for a coronavirus vaccine, 70 candidates, 3 at human trial stage

Amid the coronavirus disease (COVID-19) global pandemic that is infecting millions of people across the globe, hope sparks as the World Health Organization (WHO) reports that seventy vaccination trials for the novel coronavirus are underway, with three already at the human trial stage.

14 Apr 2020

UK collaborates with Google, Apple on contact tracing App

The UK Health Secretary Matt Hancock recently announced that the UK government’s National Health Service (NHS) is planning to release an app that will alert people who have been in the proximity of a self-reported symptomatic individual – via anonymous phone-to-phone alerts.

14 Apr 2020

Coronavirus misinformation and disinformation rife among Americans

A new poll carried out by the Pew Research Center from March 10 to March 16, 2020, shows that almost 1 in 3 Americans think the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that causes the current COVID-19 pandemic is the product of biological research. Despite the utter lack of evidence, the claim has found fertile breeding grounds on the Internet. It serves as an apt example of the spread of dubious or patently false information about the pandemic.

14 Apr 2020

New blood test for antibodies in COVID-19 infected

The COVID-19 disease pandemic is raging across the world, costing tens of thousands of lives. Many countries have enforced widespread, if not universal lockdowns, to prevent the spread of the virus to new areas, carried by infected travelers.

14 Apr 2020

Continual surveillance of natural bats for emerging viruses is needed

Findings from a study conducted by Chinese researchers suggest that similar species of bats carry similar viruses and that when these bats reside in overlapping areas, transmission between species occurs more easily.

14 Apr 2020

Stray dogs possible origin of COVID-19 pandemic

After tracing coronavirus signatures in different species, a new research article published in the journal Molecular Biology and Evolution shows that stray dogs (more specifically dog intestines) may have acted as the origin of current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

14 Apr 2020

New vaccine for Chikungunya reported safe and well-tolerated

A virus-like particle vaccine was shown to be safe and well-tolerated among a healthy adult population living in chikungunya endemic areas, the researchers report in a new study published in the Journal of the American Medical Association (JAMA).

14 Apr 2020

California COVID-19 herd immunity theory debunked

A recent theory suggesting that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was doing the rounds in California as early as November 2019, infecting thousands undetected and leading to herd immunity, was debunked by experts from the scientific community. Antibody testing by a group of Stanford Medicine researchers was linked to the theory.

14 Apr 2020

Ebola drug effective against key enzyme of coronavirus that causes COVID-19

Scientists at the University of Alberta have shown that the drug remdesivir is highly effective in stopping the replication mechanism of the coronavirus that causes COVID-19, according to new research published today in the Journal of Biological Chemistry.

13 Apr 2020

Re-thinking the built environment to limit coronavirus transmission

The coronavirus disease (COVID-19) global pandemic has taken a toll on many countries across the globe. The hardest-hit countries are now grappling to contain the spread of various through social distancing measures, while others are now in total lockdown.

13 Apr 2020

How does COVID-19 attack the body?

The coronavirus disease (COVID-19) attacks the lungs, leading to pneumonia, and eventually, a cascade of serious complications. But how does COVID-19 kill? Is it the virus itself or the result of the person’s immune system response?

13 Apr 2020

Novel coronavirus attacks and destroys T cells, just like HIV

The immune system has many components that work together in protecting the body from foreign invaders. One of the most important types of immune cells is T lymphocytes or T cells, a type of white blood cell that acts as the core of adaptive immunity, the system that modifies the immune response to specific pathogens.

13 Apr 2020

Extend lockdowns to stave off second wave of COVID-19

Social distancing, keeping people at home, and lockdowns are being implemented in many nations to prevent the spread of the highly infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some countries that have seen declines in the number of new infections due to lockdowns are now looking to allow people to return to more normal daily routines.

13 Apr 2020

Cost of ‘repurposing’ existing drugs to treat COVID-19

The paper looks at repurposed drugs that might demonstrate efficacy against COVID-19, and if they could be manufactured profitably at very low costs to ensure affordable access to vital treatments for COVID-19 at low prices globally.

13 Apr 2020